Robotic Lung Biopsy Market Detail Analysis of Current and Future Projection 2023 to 2033

The global Robotic Lung Biopsy Market Sales value is expected to increase from US$ 408.0 Million in 2023 to US$ 1,023.05 Million by 2033. Over the next decade (2023 to 2033), global Robotic Lung Biopsy demand is forecast to surge at 9.6% CAGR.

The Robotic Lung Biopsy industry is driven by several factors. This includes the minimally invasive nature of robotic lung biopsies, the growing demand for personalized medicine, and the increasing prevalence of lung cancer.

Robotic Lung Biopsy refers to a minimally invasive procedure performed using robotic-assisted technology to obtain tissue samples from the lungs for diagnostic purposes. It involves the use of a robotic system, typically controlled by a surgeon, to guide the biopsy needle to the targeted lung lesion.

During a Robotic Lung Biopsy, the patient is placed under general anesthesia. The surgeon makes small incisions in the chest, through which robotic arms with specialized instruments and a camera are inserted. The surgeon controls the robotic system from a console, manipulating the instruments with precision and accuracy.

Lung cancer is one of the leading causes of cancer-related deaths worldwide. As the incidence of lung cancer continues to rise, there is a growing demand for advanced diagnostic and treatment methods. This includes Robotic Lung Biopsy, which can accurately diagnose lung tumors and guide treatment decisions.

Robotic Lung Biopsy procedures are minimally invasive compared to open surgical biopsies. They involve smaller incisions, reduced trauma to the patient, and faster recovery times. This less invasive approach appeals to both patients and healthcare providers, leading to increased adoption of Robotic Lung Biopsy techniques.

There is also a growing focus on personalized medicine, which aims to provide tailored treatment options based on individual patient characteristics. Robotic Lung Biopsy plays a crucial role in obtaining tissue samples for molecular testing, which helps identify specific genetic mutations or biomarkers that can guide targeted therapies.

Key Players in the Robotic Lung Biopsy Industry

  • Ethicon, Inc. (Johnson & Johnson)
  • Intuitive Surgical

Get More Insights@ https://www.futuremarketinsights.com/reports/robotic-lung-biopsy-market

Robotic Lung Biopsy Market Segmentation

By Product and Services:

  • System
  • Instruments and Accessories
  • Service

By Navigation Technology:

  • Electromagnetic and Optical Navigation
  • Fiber Optic RealShape Navigation

By End User:

  • Hospitals
  • Ambulatory Surgical Centers

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasoun...
Read more

Global Medical face shield Market Insights and Outlook 2022-2032

Image
Medical face shield can become as ubiquitous as masks, as new findings on the airborne spread of Covid-19 influence behavior and guidelines. According to a latest study by Future Market Insights,  Medical Face Shields Market  will grow at over 11% CAGR through 2030. Medical face shields have proven to be an effective first-line defence against airborne diseases such as Zika, SARS, Ebola, flu, and now Covid-19. As a result, increased adoption of medical face shields, and thus increased production, is expected to drive the market during the forecast period. The IDSA (Infectious Diseases Society of America) has included the use of PPE (Personal Protective Equipment) such as face shields and masks in its recommendations. Though masks have been widely used throughout the world, their effectiveness is not widely known. The possibility of cloth masks providing marginal virus protection due to potential moisture retention, poor filtration, and re-use cannot be ruled out. Face ...
Read more

Aesthetic Medical Devices Market 2022-2032: Advanced R&D Process Strategies

Image
A recently published study by FMI expects the global  Aesthetic Medical Devices Market  to augment at a 9.6% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 35000 Million is expected for the market. The increase may be attributed mostly to the increased development of technologically advanced and user-friendly devices, as well as the rising desire for cosmetic treatments among individuals. In addition to that, the popularity of minimally invasive and non-invasive aesthetic operations is expanding internationally as a result of loose facial skin, particularly around the eyes, jowls, and cheeks; and dry or roughened skin, among other important changes that occur as a person ages. Furthermore, the demand for aesthetic devices is rising due to the growing popularity of cosmetic operations among those seeking to improve their looks and stand out from the crowd. Key Takeaways from the Market Study FMI projects the global aesthetic ...
Read more